Company
Harrow Eye
Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
21
17 still marketed
Novel approvals
3
Approvals since 2021
5
Originals and new uses
Phase 3 trials
0
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
- Byqlovi approved Mar 4, 2024
- Vevye approved May 30, 2023
- Iheezo approved Sep 27, 2022
- Tyrvaya approved Oct 15, 2021
- Verkazia approved OrphanJun 23, 2021
- Zerviate approved Priority reviewMay 30, 2017
- Ilevro approved Oct 16, 2012
- Moxeza approved Nov 19, 2010
- Tobradex St approved Feb 13, 2009
- Triesence approved Priority reviewNov 29, 2007
Drugs in development (0)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
No investigational drugs in Phase 2 or 3 trials under this sponsor name.
Recruiting Phase 3 trials
Largest first.
No recruiting Phase 3 trials under this sponsor name.
Marketed drugs (17)
Newest FDA action first.
- Iopidine Apraclonidine Hydrochloride · 1993
- Iopidine Apraclonidine Hydrochloride · 1987
- Tobradex St Dexamethasone, Tobramycin · 2009
- Natacyn Natamycin · 1978
- Flarex Fluorometholone Acetate · 1986
- Vevye Cyclosporine · 2023
- Byqlovi Clobetasol Propionate · 2024
- Tyrvaya Varenicline Tartrate · 2021
- Iheezo Chloroprocaine Hydrochloride · 2022
- Maxidex Dexamethasone · 1962
- Verkazia Cyclosporine · 2021
- Maxitrol Dexamethasone, Neomycin Sulfate, Polymyxin B Sulfate · 1963
- Nevanac Nepafenac · 2005
- Vigamox Moxifloxacin Hydrochloride · 2003
- Zerviate Cetirizine Hydrochloride · 2017
- Ilevro Nepafenac · 2012
- Triesence Triamcinolone Acetonide · 2007
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.